| Choice | Drug | Dosage |
|---|---|---|
1st choice For information Specialist initiation only | Methylphenidate prolonged-release tablets/capsules Prescribe By Brand Name | Dose: See BNF for dosing [off-label use of some preparations of methylphenidate] |
2nd choice For information Specialist initiation only | Methylphenidate standard release tablets 5mg, 10mg, 20mg | Dose: See BNF for dosing [off-label use] |
Prescribing Notes
- Refer to NICE NG87 ADHD guidance.
- NICE recommend methylphenidate or lisdexamfetamine as first line pharmacological treatments for adults with ADHD. Refer to NICE for further information and for details of other treatment options.
- Methylphenidate and lisdexamfetamine are amber list drugs and should only be initiated by a specialist with expertise in ADHD- see Shared Care Guideline.
- Modified-release preparations of methylphenidate should be prescribed by brand. GPs should prescribe the brand of methylphenidate that has been recommended by the specialist.
- MHRA advises to use caution if switching patients between different long-acting formulations of methylphenidate.